Thierry Poynard

All Stories

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort

Article • October 2025, MDPI AG

Thierry Poynard
Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Article • Diagnostics, May 2025, MDPI AG

Thierry Poynard
Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Article • March 2025, MDPI AG

Thierry Poynard
Prospective direct comparison of non‐invasive liver tests in outpatients with type 2 diabetes using intention‐to‐diagnose analysis

Article • Alimentary Pharmacology & Therapeutics, August 2023, Wiley

Thierry Poynard
Liver Assessment in Patients with Ataxia-Telangiectasia: Transient Elastography Detects Early Stages of Steatosis and Fibrosis

Article • Canadian Journal of Gastroenterology and Hepatology, March 2023, Wiley

Thierry Poynard
Response to: Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications, by Jerome Boursier et al

Article • Clinical Gastroenterology and Hepatology, February 2023, Elsevier

Thierry Poynard
External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B

Article • Gastro Hep Advances, January 2022, Elsevier

Thierry Poynard
Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection

Article • Gastro Hep Advances, January 2022, Elsevier

Thierry Poynard
Prospective external validation of a new non‐invasive test for the diagnosis of non‐alcoholic steatohepatitis in patients with type 2 diabetes

Article • Alimentary Pharmacology & Therapeutics, August 2021, Wiley

Thierry Poynard
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV

Article • JHEP Reports, August 2021, Elsevier

Thierry Poynard
Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virus

Article • World Journal of Hepatology, December 2020, Baishideng Publishing Group Co., Limited (formerly WJG Press)

Thierry Poynard
Performance of serum apolipoprotein-A1 as a sentinel of Covid-19

Article • PLOS One, November 2020, PLOS

Thierry Poynard
Transportation and handling of blood samples prior to ammonia measurement in the real life of a large university hospital

Article • Clinica Chimica Acta, November 2020, Elsevier

Thierry Poynard
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta

Article • Journal of Hepatology, November 2020, Elsevier

Thierry Poynard
Posters

Article • Hepatology, October 2020, Wiley

Sergey Morozov, Thierry Poynard
Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease

Article • Clinics and Research in Hepatology and Gastroenterology, October 2020, Elsevier

Thierry Poynard
Performance of serum apolipoprotein-A1 as a sentinel of Covid-19

Article • September 2020, Cold Spring Harbor Laboratory Press

Thierry Poynard
Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease

Article • Journal of Hepatology, May 2020, Elsevier

Thierry Poynard
Evaluation of Point Shear Wave Elastography Using Acoustic Radiation Force Impulse Imaging for Longitudinal Fibrosis Assessment in Patients with HBeAg-Negative HBV Infection

Article • Journal of Clinical Medicine, December 2019, MDPI AG

Thierry Poynard
Intestinal failure-associated liver disease in patients with short bowel syndrome: Evaluation by transient elastography

Article • Nutrition, July 2019, Elsevier

Thierry Poynard
Liver Fibrosis Determination

Article • Gastroenterology Clinics of North America, June 2019, Elsevier

Thierry Poynard
External validation of an algorithm combining multi‐analyte blood tests (FibroTest‐LCR1‐LCR2) to identify subjects at risk of hepatocellular carcinoma in patients with chronic liver disease

Article • GastroHep, May 2019, Wiley

Thierry Poynard
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis

Article • European Journal of Gastroenterology & Hepatology, March 2019, Wolters Kluwer Health

Thierry Poynard
Editorial: simplifying screening for primary liver cancer - do the LCR1 and LCR2 tests hold the key? Authors' reply

Article • Alimentary Pharmacology & Therapeutics, February 2019, Wiley

Thierry Poynard
Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus–Associated Cryoglobulinemia Vasculitis

Article • Clinical Gastroenterology and Hepatology, February 2019, Elsevier

Thierry Poynard
Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencing

Article • International Journal of Antimicrobial Agents, January 2019, Elsevier

Thierry Poynard
LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis

Article • Alimentary Pharmacology & Therapeutics, December 2018, Wiley

Thierry Poynard
Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease

Article • Alimentary Pharmacology & Therapeutics, October 2018, Wiley

Thierry Poynard
Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus

Article • Journal of Investigative Medicine, October 2018, BMJ

Michael McPhaul, Thierry Poynard
Predictive value of liver damage for severe early complications and survival after heart transplantation: A retrospective analysis

Article • Clinics and Research in Hepatology and Gastroenterology, October 2018, Elsevier

Thierry Poynard
Dronedarone, amiodarone and other antiarrhythmic drugs, and acute liver injuries: a case-referent study

Article • International Journal of Cardiology, September 2018, Elsevier

Thierry Poynard
Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort

Article • Hepatology, June 2018, Wiley

Thierry Poynard
Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference

Article • European Journal of Gastroenterology & Hepatology, May 2018, Wolters Kluwer Health

Thierry Poynard
Impact of steatosis and inflammation definitions on the performance of NASH tests

Article • European Journal of Gastroenterology & Hepatology, April 2018, Wolters Kluwer Health

Thierry Poynard
Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective

Article • Antiviral Therapy, January 2018, International Medical Press

Thierry Poynard
Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery

Article • PLOS One, December 2017, PLOS

Thierry Poynard
Cystic Fibrosis–related Liver Disease

Article • Journal of Pediatric Gastroenterology and Nutrition, October 2017, Wolters Kluwer Health

Thierry Poynard
Impact of graft preservation solutions for liver transplantation on early cytokine release and postoperative organ dysfunctions. A pilot study

Article • Clinics and Research in Hepatology and Gastroenterology, October 2017, Elsevier

Thierry Poynard
Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis

Article • Gastroenterology, July 2017, Elsevier

Thierry Poynard
Chronic hepatitis E in HIV/HBV coinfected patient

Article • AIDS, June 2017, Wolters Kluwer Health

Thierry Poynard
Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus–Induced Cryoglobulinemia Vasculitis

Article • Gastroenterology, June 2017, Elsevier

Thierry Poynard
Screening studies of transient elastography and FibroTest in the general population

Article • The Lancet Gastroenterology & Hepatology, April 2017, Elsevier

Thierry Poynard
NAFLD and liver transplantation: Current burden and expected challenges

Article • Journal of Hepatology, December 2016, Elsevier

Thierry Poynard
Real-Time Shear Wave versus Transient Elastography for Predicting Fibrosis: Applicability, and Impact of Inflammation and Steatosis. A Non-Invasive Comparison

Article • PLOS One, October 2016, PLOS

Thierry Poynard
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference

Article • Alimentary Pharmacology & Therapeutics, August 2016, Wiley

Thierry Poynard
BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease

Article • Oncotarget, August 2016, Impact Journals, LLC

Thierry Poynard
A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients

Article • Hepatology, July 2016, Wiley

Thierry Poynard
Fatty liver is an independent predictor of early carotid atherosclerosis

Article • Journal of Hepatology, July 2016, Elsevier

Thierry Poynard
Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion

Article • PLOS One, June 2016, PLOS

Thierry Poynard
Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury

Article • Liver International, June 2016, Wiley

Professor M Isabel Lucena, Thierry Poynard
Remodeling of B-Cell Subsets in Blood during Pegylated IFNα-2a Therapy in Patients with Chronic Hepatitis B Infection

Article • PLOS One, June 2016, PLOS

Thierry Poynard
Critical comparison of elastography methods to assess chronic liver disease

Article • Nature Reviews Gastroenterology & Hepatology, June 2016, Springer Science + Business Media

Thierry Poynard
Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease

Article • BMJ Open Gastroenterology, March 2016, BMJ

Thierry Poynard
Rate of employment after liver transplantation in France

Article • European Journal of Gastroenterology & Hepatology, February 2016, Wolters Kluwer Health

Thierry Poynard
Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study

Article • PLOS One, December 2015, PLOS

Thierry Poynard
Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity

Article • BMJ Open, December 2015, BMJ

Thierry Poynard
Hepatitis E infection in patients with severe alcoholic hepatitis

Article • European Journal of Gastroenterology & Hepatology, December 2015, Wolters Kluwer Health

Thierry Poynard
Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study

Article • Annals of the Rheumatic Diseases, November 2015, BMJ

Thierry Poynard
Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B

Article • Alimentary Pharmacology & Therapeutics, October 2015, Wiley

Thierry Poynard
Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis

Article • PLOS One, August 2015, PLOS

Thierry Poynard
The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patients

Article • Journal of Viral Hepatitis, July 2015, Wiley

Thierry Poynard
Point Shear Wave Elastography by Acoustic Radiation Force Impulse Quantification in Comparison to Transient Elastography for the Noninvasive Assessment of Liver Fibrosis in Chronic Hepatitis C: A Prospective International Multicenter Study

Article • Ultraschall in der Medizin - European Journal of Ultrasound, May 2015, Thieme Publishing Group

Thierry Poynard
Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Associated Cirrhosis Awaiting Liver Transplants

Article • Clinical Gastroenterology and Hepatology, May 2015, Elsevier

Thierry Poynard
Spontaneous ascitic fluid infection and bacteremia due to Yersinia pseudotuberculosis in a liver transplant patient

Article • International Journal of Infectious Diseases, May 2015, Elsevier

Thierry Poynard
An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: The Liver-FibroSTARD standards

Article • Journal of Hepatology, April 2015, Elsevier

Dr JEROME GUECHOT, Thierry Poynard
Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleeding

Article • Journal of Hepatology, April 2015, Elsevier

Thierry Poynard
Significant Variations in Elastometry Measurements Made Within Short-term in Patients With Chronic Liver Diseases

Article • Clinical Gastroenterology and Hepatology, April 2015, Elsevier

Thierry Poynard
P0768 : Late mortality in treatment-experienced cirrhotic patients treated with triple therapy including boceprevir or telaprevir in a real-life cohort - ANRS Co 20 cupic

Article • Journal of Hepatology, April 2015, Elsevier

Thierry Poynard
Definition of an HBsAg to DNA international unit conversion factor by enrichment of circulating hepatitis B virus forms

Article • Journal of Viral Hepatitis, January 2015, Wiley

Thierry Poynard
Liver-FibroSTARD checklist and glossary: tools for standardized design and reporting of diagnostic accuracy studies of liver fibrosis tests

Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2015, De Gruyter

Dr JEROME GUECHOT, Thierry Poynard
Coexistence of circulating HBsAg and anti-HBs antibodies in chronic hepatitis B carriers is not a simple analytical artifact and does not influence HBsAg quantification

Article • Journal of Clinical Virology, January 2015, Elsevier

Thierry Poynard
Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease

Article • European Journal of Internal Medicine, January 2015, Elsevier

Thierry Poynard
Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®)

Article • Journal of Hepatology, November 2014, Elsevier

Thierry Poynard
Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival

Article • Alimentary Pharmacology & Therapeutics, September 2014, Wiley

Thierry Poynard
Impact of common risk factors of fibrosis progression in chronic hepatitis C

Article • Gut, September 2014, BMJ

Thierry Poynard
Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia

Article • Alimentary Pharmacology & Therapeutics, September 2014, Wiley

Thierry Poynard
Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: “APRI c’est fini ?”

Article • Clinics and Research in Hepatology and Gastroenterology, September 2014, Elsevier

Dr Denis Monneret, Thierry Poynard
Spleen Stiffness Measurement by Transient Elastography to Diagnose Portal Hypertension in Children

Article • Journal of Pediatric Gastroenterology and Nutrition, August 2014, Wolters Kluwer Health

Thierry Poynard
Biopsy as well as FibroTest/Fibrosure Is Suboptimal for Discriminating Intermediate Fibrosis Stages in Patients With Chronic Hepatitis B

Article • The American Journal of Gastroenterology, August 2014, Wolters Kluwer Health

Thierry Poynard
Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis

Article • Gastroenterology, July 2014, Elsevier

Thierry Poynard
FibroTest (FT) has similar accuracy for cirrhosis in ‘intention-to-diagnose’ which is superior to transient elastography (TE) in chronic hepatitis B.

Article • Liver International, May 2014, Wiley

Thierry Poynard
Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®)

Article • Journal of Hepatology, April 2014, Elsevier

Thierry Poynard
The Interactions of Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases

Article • Clinics in Liver Disease, February 2014, Elsevier

Thierry Poynard
The new paradigm of hepatitis C therapy: integration of oral therapies into best practices

Article • Journal of Viral Hepatitis, October 2013, Wiley

Thierry Poynard
Anti-hepatitis C virus antibody detection in oral fluid: Influence of human immunodeficiency virus co-infection

Article • Journal of Clinical Virology, October 2013, Elsevier

Thierry Poynard
Corrigendum to: “FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program” [J Hepatol 2011;54:227–235]

Article • Journal of Hepatology, October 2013, Elsevier

Thierry Poynard
Correction

Article • Gastroenterology, October 2013, Elsevier

Thierry Poynard
Role of genotype G hepatitis B virus mixed infection on the progression of hepatic fibrosis in HIV positive patients over 5 years of follow-up

Article • Journal of Clinical Virology, October 2013, Elsevier

Thierry Poynard
Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C

Article • Journal of Hepatology, October 2013, Elsevier

Thierry Poynard
Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection

Article • Annals of Internal Medicine, September 2013, American College of Physicians

Thierry Poynard
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver

Article • Journal of Hepatology, September 2013, Elsevier

Thierry Poynard
Non-invasive measurement of liver and pancreas fibrosis in patients with cystic fibrosis

Article • Journal of Cystic Fibrosis, September 2013, Elsevier

Thierry Poynard
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890

Article • Journal of Hepatology, September 2013, Elsevier

Thierry Poynard
The use of transient elastography and non-invasive serum markers of fibrosis in pediatric liver transplant recipients

Article • Pediatric Transplantation, June 2013, Wiley

Thierry Poynard
Chronic hepatitis C virus (HCV) disease burden and cost in the United States

Article • Hepatology, May 2013, Wiley

Thierry Poynard
Liver fibrosis evaluation using real-time shear wave elastography: Applicability and diagnostic performance using methods without a gold standard

Article • Journal of Hepatology, May 2013, Elsevier

Thierry Poynard
Liver Stiffness, Platelets, and Spleen Size Is Reliable in Nondecompensated Cirrhotic Patients

Article • Gastroenterology, May 2013, Elsevier

Thierry Poynard
Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin

Article • Journal of Viral Hepatitis, March 2013, Wiley

Thierry Poynard
Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: A randomized study

Article • Journal of Hepatology, March 2013, Elsevier

Thierry Poynard
Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease

Article • Alimentary Pharmacology & Therapeutics, February 2013, Wiley

Thierry Poynard
Optimal nonsurgical management of peptic ulcer bleeding, including arterial embolization is associated with a mortality below 1%

Article • Clinics and Research in Hepatology and Gastroenterology, February 2013, Elsevier

Thierry Poynard
Interferon‐gamma with peginterferon alpha‐2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI)

Article • Journal of Gastroenterology and Hepatology, January 2013, Wiley

Thierry Poynard
Reply

Article • Clinical Gastroenterology and Hepatology, December 2012, Elsevier

Thierry Poynard
Genome-Wide Association Study Identifies Variants Associated With Progression of Liver Fibrosis From HCV Infection

Article • Gastroenterology, November 2012, Elsevier

Thierry Poynard
Performances of Elasto-FibroTest®, a combination between FibroTest® and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C

Article • Clinics and Research in Hepatology and Gastroenterology, October 2012, Elsevier

Thierry Poynard
Factors That Predict Response of Patients With Hepatitis C Virus Infection to Boceprevir

Article • Gastroenterology, September 2012, Elsevier

Thierry Poynard
Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population

Article • Journal of Hepatology, September 2012, Elsevier

Thierry Poynard
Low 25-hydroxyvitamin D serum levels correlate with the presence of extra-hepatic manifestations in chronic hepatitis C virus infection

Article • Rheumatology, August 2012, Oxford University Press (OUP)

Thierry Poynard
Real Time Identification of Drug-Induced Liver Injury (DILI) through Daily Screening of ALT Results: A Prospective Pilot Cohort Study

Article • PLOS One, August 2012, PLOS

Thierry Poynard
Cost-effectiveness modeling of colorectal cancer: Computed tomography colonography vs colonoscopy or fecal occult blood tests

Article • European Journal of Radiology, July 2012, Elsevier

Thierry Poynard
Liver Biopsy Analysis Has a Low Level of Performance for Diagnosis of Intermediate Stages of Fibrosis

Article • Clinical Gastroenterology and Hepatology, June 2012, Elsevier

Thierry Poynard
Peptic ulcer bleeding in patients with or without cirrhosis: different diseases but the same prognosis?

Article • Alimentary Pharmacology & Therapeutics, May 2012, Wiley

Thierry Poynard
Gastric mucormycosis: A rare cause of gastrointestinal bleeding in cirrhosis

Article • Clinics and Research in Hepatology and Gastroenterology, April 2012, Elsevier

Thierry Poynard
Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers

Article • BMC Gastroenterology, March 2012, Springer Science + Business Media

Thierry Poynard
Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data

Article • PLOS One, March 2012, PLOS

Thierry Poynard
Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: A step toward the truth in the absence of a gold standard

Article • Journal of Hepatology, March 2012, Elsevier

Thierry Poynard
Evolution of biomarkers of liver fibrosis and liver insufficiency in hepatitis C virus-infected patients treated with pegylated interferon plus ribavirin and rituximab

Article • Journal of Viral Hepatitis, January 2012, Wiley

Thierry Poynard
Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: A retrospective repeated liver biopsy analysis

Article • Journal of Hepatology, January 2012, Elsevier

Thierry Poynard
Touching some firm ground in the epidemiology of NASH

Article • Journal of Hepatology, January 2012, Elsevier

Thierry Poynard
Comparison of acoustic radiation force impulse imaging with transient elastography for the detection of complications in patients with cirrhosis

Article • Liver International, December 2011, Wiley

Thierry Poynard
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes

Article • Hepatology, December 2011, Wiley

Thierry Poynard
FibroTest® and Fibroscan® performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate

Article • Clinics and Research in Hepatology and Gastroenterology, November 2011, Elsevier

Thierry Poynard
Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis

Article • Journal of Hepatology, October 2011, Elsevier

Thierry Poynard
The Risk of Multiplying Diagnostic Combinations in the Absence of a Perfect Gold Standard For a Fibrosis Test

Article • The American Journal of Gastroenterology, October 2011, Wolters Kluwer Health

Thierry Poynard
Recombinant activated factor VII in chronic liver diseases: Should we be afraid of thromboembolic events?

Article • Journal of Hepatology, August 2011, Elsevier

Thierry Poynard
What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI)

Article • Regulatory Toxicology and Pharmacology, August 2011, Elsevier

Thierry Poynard
FibroStic: A large confirmatory study for non-invasive biomarkers accuracy, if correctly interpreted

Article • Journal of Hepatology, July 2011, Elsevier

Thierry Poynard
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

Article • Liver International, June 2011, Wiley

Thierry Poynard
Maintenance Therapy With Peginterferon Alfa-2b Does Not Prevent Hepatocellular Carcinoma in Cirrhotic Patients With Chronic Hepatitis C

Article • Gastroenterology, June 2011, Elsevier

Thierry Poynard
Ranking Hepatologists: Which Hirsch's h-Index to prevent the “e-crise de foi-e”?

Article • Clinics and Research in Hepatology and Gastroenterology, May 2011, Elsevier

Thierry Poynard
Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age

Article • BMC Gastroenterology, April 2011, Springer Science + Business Media

Thierry Poynard
Boceprevir for Untreated Chronic HCV Genotype 1 Infection

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2011, New England Journal of Medicine (NEJM/MMS)

Thierry Poynard
First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsy

Article • Journal of Hepatology, March 2011, Elsevier

Thierry Poynard
Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B

Article • Current Hepatology Reports, March 2011, Springer Science + Business Media

Thierry Poynard
Perioperative management of combined heart-liver transplantation in patients with cirrhosis, renal insufficiency, or pulmonary hypertension

Article • Clinical Transplantation, March 2011, Wiley

Thierry Poynard
FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program

Article • Journal of Hepatology, February 2011, Elsevier

Thierry Poynard
Performance of the FibroTest cannot be accurately estimated in nine paediatric patients with advanced fibrosis

Article • Scandinavian Journal of Infectious Diseases, January 2011, Taylor & Francis

Thierry Poynard
Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease

Article • Clinics and Research in Hepatology and Gastroenterology, January 2011, Elsevier

Thierry Poynard
High rate of adefovir–lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France

Article • European Journal of Gastroenterology & Hepatology, November 2010, Wolters Kluwer Health

Thierry Poynard
Early Use of TIPS for Cirrhosis and Variceal Bleeding

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2010, New England Journal of Medicine (NEJM/MMS)

Thierry Poynard
Hirsch Index and Truth Survival in Clinical Research

Article • PLOS One, August 2010, PLOS

Thierry Poynard
A comparison of the fibrotic potential of nonalcoholic fatty liver disease and chronic hepatitis C

Article • Human Pathology, August 2010, Elsevier

Thierry Poynard
ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure

Article • Gastroentérologie Clinique et Biologique, August 2010, Elsevier

Thierry Poynard
Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus

Article • Gastroenterology, July 2010, Elsevier

Professor Eric J Lawitz, Thierry Poynard
Interferon receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection

Article • Gut, June 2010, BMJ

Thierry Poynard
Assessment of adrenal function in cirrhotic patients: Salivary cortisol should be preferred

Article • Journal of Hepatology, June 2010, Elsevier

Thierry Poynard
Toxicité hépatique de la chimiothérapie du cancer colorectal métastatique: revue de la littérature

Article • Bulletin du Cancer, May 2010, Elsevier

Thierry Poynard
Pentoxifylline Does Not Decrease Short-term Mortality but Does Reduce Complications in Patients With Advanced Cirrhosis

Article • Gastroenterology, May 2010, Elsevier

Thierry Poynard
Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

Article • BMC Gastroenterology, April 2010, Springer Science + Business Media

Thierry Poynard
Comparison of Elastography, Serum Marker Scores, and Histology for the Assessment of Liver Fibrosis in Hepatitis B Virus (HBV)-Infected Patients in Burkina Faso

Article • American Journal of Tropical Medicine and Hygiene, March 2010, American Society of Tropical Medicine and Hygiene

Thierry Poynard
Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

Article • Gastroenterology, February 2010, Elsevier

Thierry Poynard
Evaluation of FibroTest inter-laboratory variations requires standardization on analytical systems and should not be mixed with underpowered histological validation

Article • Clinica Chimica Acta, February 2010, Elsevier

Thierry Poynard
Assessment of Liver Fibrosis and Steatosis in PBC With FibroScan, MRI, MR-spectroscopy, and Serum Markers

Article • Journal of Clinical Gastroenterology, January 2010, Wolters Kluwer Health

Thierry Poynard
Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies

Article • Antiviral Therapy, January 2010, International Medical Press

Thierry Poynard
Evaluation of FibroTest–ActiTest in children with chronic hepatitis C virus infection

Article • Gastroentérologie Clinique et Biologique, January 2010, Elsevier

Thierry Poynard
Factors to Improve the Management of Hepatitis C in Drug Users: An Observational Study in an Addiction Centre

Article • Gastroenterology Research and Practice, January 2010, Hindawi Publishing Corporation

Thierry Poynard
Perspectives on fibrosis progression in hepatitis C: an á la carte approach to risk factors and staging of fibrosis

Article • Antiviral Therapy, January 2010, International Medical Press

Thierry Poynard
Appropriate evidence-based data overviews demonstrate the diagnostic and prognostic performances of FibroTest in patients with chronic hepatitis C

Article • Alimentary Pharmacology & Therapeutics, December 2009, Wiley

Thierry Poynard
Similarities and Differences Between REPEAT and EPIC3

Article • Annals of Internal Medicine, November 2009, American College of Physicians

Thierry Poynard
Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy

Article • Journal of Medical Virology, October 2009, Wiley

Professor Bruno Pozzetto, Thierry Poynard
Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: An overview of published trials

Article • Gastroentérologie Clinique et Biologique, October 2009, Elsevier

Thierry Poynard
Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial

Article • Hepatology, September 2009, Wiley

Thierry Poynard
Natural Variability of NS3 Protease in Patients Infected with Genotype 4 Hepatitis C Virus (HCV): Implications for Antiviral Treatment Using Specifically Targeted Antiviral Therapy for HCV

Article • The Journal of Infectious Diseases, August 2009, Oxford University Press (OUP)

Thierry Poynard
Can nonalcoholic steatohepatitis be diagnosed without liver biopsy?

Article • Biomarkers in Medicine, August 2009, Future Medicine

Thierry Poynard
Liver Fibrosis in Viral Hepatitis: Noninvasive Assessment with Acoustic Radiation Force Impulse Imaging versus Transient Elastography

Article • Radiology, August 2009, Radiological Society of North America (RSNA)

Thierry Poynard
Stéatohépatite métabolique : 30 ans de recherches qui ont changé la NASH

Article • Gastroentérologie Clinique et Biologique, August 2009, Elsevier

Thierry Poynard
Baseline characteristics and early on-treatment response predict the outcomes of 2years of telbivudine treatment of chronic hepatitis B

Article • Journal of Hepatology, July 2009, Elsevier

Thierry Poynard
Liver biopsy: The best standard…when everything else fails

Article • Journal of Hepatology, June 2009, Elsevier

Thierry Poynard
Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy

Article • Gastroenterology, May 2009, Elsevier

Thierry Poynard
The risks of changing the rules for previously validated biomarkers and using the same patients several times. Response letter to Calès et al. Gastroenterol Clin Biol 2008;32:1050–60: “Evaluation and improvement of a reliable diagnosis of cirrhosis by ...

Article • Gastroentérologie Clinique et Biologique, May 2009, Elsevier

Thierry Poynard
Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure

Article • Liver International, March 2009, Wiley

Thierry Poynard
Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus

Article • Journal of Viral Hepatitis, March 2009, Wiley

Thierry Poynard
Immediate Listing for Liver Transplantation Versus Standard Care for Child–Pugh Stage B Alcoholic Cirrhosis

Article • Annals of Internal Medicine, February 2009, American College of Physicians

Thierry Poynard
Discordance between results of biomarkers of fibrosis shows that it is at least a “ménage à deux”

Article • Gastroentérologie Clinique et Biologique, February 2009, Elsevier

Thierry Poynard
Applicability and variability of liver stiffness measurements according to probe position

Article • World Journal of Gastroenterology, January 2009, Baishideng Publishing Group Co., Limited (formerly WJG Press)

Thierry Poynard
The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption

Article • European Journal of Gastroenterology & Hepatology, January 2009, Wolters Kluwer Health

Thierry Poynard
Perisinusoidal cells (Ito-cells) enlargement in a family with myotonic dystrophy

Article • Liver International, December 2008, Wiley

Thierry Poynard
The inconvenience of investigations used in hepatology: patients' and hepatologists' opinions

Article • Liver International, December 2008, Wiley

Thierry Poynard
Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy

Article • Hepatology, December 2008, Wiley

Thierry Poynard
Concordance in a World without a Gold Standard: A New Non-Invasive Methodology for Improving Accuracy of Fibrosis Markers

Article • PLOS One, December 2008, PLOS

Thierry Poynard
Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency

Article • Hepatology, November 2008, Wiley

Thierry Poynard
FibroTest-ActiTest as a non-invasive marker of liver fibrosis

Article • Gastroentérologie Clinique et Biologique, September 2008, Elsevier

Thierry Poynard
Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update

Article • Gastroentérologie Clinique et Biologique, September 2008, Elsevier

Thierry Poynard
Reproducibility of non-invasive fibrosis biomarkers, FibroMeter and FibroTest, could be improved by respecting the analytical standardizations

Article • Clinical Biochemistry, September 2008, Elsevier

Thierry Poynard
Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease

Article • Hepatology, August 2008, Wiley

Thierry Poynard
An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load

Article • PLOS One, July 2008, PLOS

Thierry Poynard
Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial

Article • Gastroenterology, July 2008, Elsevier

Thierry Poynard
Screening for Liver Fibrosis by Using a Noninvasive Biomarker in Patients With Diabetes

Article • Clinical Gastroenterology and Hepatology, July 2008, Elsevier

Thierry Poynard
Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma

Article • Cancer, June 2008, Wiley

Thierry Poynard
FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence

Article • Journal of Viral Hepatitis, June 2008, Wiley

Thierry Poynard
Adhésion à la bithérapie pégylée au cours de l’hépatite chronique C

Article • Gastroentérologie Clinique et Biologique, March 2008, Elsevier

Thierry Poynard
Évaluation non-invasive de la fibrose hépatique au cours de l’hépatite C

Article • Gastroentérologie Clinique et Biologique, March 2008, Elsevier

Thierry Poynard
Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers

Article • Journal of Thoracic and Cardiovascular Surgery, March 2008, Elsevier

Thierry Poynard
Assessment of liver fibrosis: Noninvasive means

Article • Saudi Journal of Gastroenterology, January 2008, Medknow

Thierry Poynard
Chapter 4 Biomarkers Of Liver Fibrosis

Article • January 2008, Elsevier

Thierry Poynard
Nodular regenerative hyperplasia: The main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities

Article • Journal of Hepatology, January 2008, Elsevier

Thierry Poynard
FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C

Article • Hepatology, December 2007, Wiley

Thierry Poynard
Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis with Telbivudine or Adefovir

Article • Annals of Internal Medicine, December 2007, American College of Physicians

Prof Henry LY Chan, Thierry Poynard
High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats

Article • Hepatology, December 2007, Wiley

Thierry Poynard
Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure

Article • Hepatology, December 2007, Wiley

Thierry Poynard
Meta-analyses of FibroTest diagnostic value in chronic liver disease

Article • BMC Gastroenterology, October 2007, Springer Science + Business Media

Thierry Poynard
Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C

Article • Gastroentérologie Clinique et Biologique, October 2007, Elsevier

Thierry Poynard
FibroMAX™: towards a new universal biomarker of liver disease?

Article • Expert Review of Molecular Diagnostics, September 2007, Taylor & Francis

Thierry Poynard
Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages

Article • Clinical Chemistry, September 2007, AACC

Thierry Poynard
Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C

Article • Alimentary Pharmacology & Therapeutics, July 2007, Wiley

Thierry Poynard
Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability

Article • Alimentary Pharmacology & Therapeutics, July 2007, Wiley

Thierry Poynard
Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection

Article • Journal of Viral Hepatitis, July 2007, Wiley

Thierry Poynard
Relationship between the Fibrotest and portal hypertension in patients with liver disease

Article • Alimentary Pharmacology & Therapeutics, May 2007, Wiley

Thierry Poynard
Effect of Prolonged Interferon Therapy on the Outcome of Hepatitis C Virus–Related Cirrhosis: A Randomized Trial

Article • Clinical Gastroenterology and Hepatology, April 2007, Elsevier

Thierry Poynard
Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC)

Article • Cancer, April 2007, Wiley

Thierry Poynard
Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome

Article • Alimentary Pharmacology & Therapeutics, March 2007, Wiley

Thierry Poynard
Relapse rate of patients after healing of oesophagitis-a prospective study of alginate as self-care treatment for 6 months

Article • Alimentary Pharmacology & Therapeutics, March 2007, Wiley

Thierry Poynard
Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study

Article • Alimentary Pharmacology & Therapeutics, March 2007, Wiley

Thierry Poynard
Peut-on traiter la stéatohépatite métabolique ?

Article • Gastroentérologie Clinique et Biologique, March 2007, Elsevier

Thierry Poynard
Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States

Article • Journal of Viral Hepatitis, February 2007, Wiley

Thierry Poynard
Faut-il encore faire des biopsies du foie ?

Article • La Revue de Médecine Interne, February 2007, Elsevier

Thierry Poynard
Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series

Article • BMC Gastroenterology, January 2007, Springer Science + Business Media

Thierry Poynard
Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation

Article • Alimentary Pharmacology & Therapeutics, January 2007, Wiley

Thierry Poynard
Association between Leptin, Metabolic Factors and Liver Histology in Patients with Chronic Hepatitis C

Article • Canadian Journal of Gastroenterology, January 2007, Hindawi Publishing Corporation

Thierry Poynard
Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection

Article • Hepatology, December 2006, Wiley

Thierry Poynard
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

Article • BMC Gastroenterology, November 2006, Springer Science + Business Media

Thierry Poynard
Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia

Article • Alimentary Pharmacology & Therapeutics, October 2006, Wiley

Thierry Poynard
A Prospective Analysis of the Prognostic Value of Biomarkers (FibroTest) in Patients with Chronic Hepatitis C

Article • Clinical Chemistry, October 2006, AACC

Thierry Poynard
Erratum

Article • Alimentary Pharmacology & Therapeutics, October 2006, Wiley

Thierry Poynard
Fibrosis as an End Point for Clinical Trials in Liver Disease: A Report of the International Fibrosis Group

Article • Clinical Gastroenterology and Hepatology, October 2006, Elsevier

Thierry Poynard
Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study

Article • Alimentary Pharmacology & Therapeutics, August 2006, Wiley

Thierry Poynard
Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis

Article • Clinical Biochemistry, July 2006, Elsevier

Thierry Poynard
Immune Suppression as the Etiology of Failure To Detect Anti-HBc Antibodies in Patients with Chronic Hepatitis B Virus Infection

Article • Journal of Clinical Microbiology, June 2006, ASM Journals

Thierry Poynard
Hepatitis C in 6,865 Patients 65 yr or Older: A Severe and Neglected Curable Disease?

Article • The American Journal of Gastroenterology, June 2006, Wolters Kluwer Health

Thierry Poynard
The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease

Article • Journal of Hepatology, June 2006, Elsevier

Thierry Poynard
Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen status

Article • Journal of Viral Hepatitis, May 2006, Wiley

Thierry Poynard
A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine

Article • Journal of Viral Hepatitis, April 2006, Wiley

Thierry Poynard
Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study

Article • Liver International, April 2006, Wiley

Thierry Poynard
Coexistence of Hepatitis B Surface Antigen (HBs Ag) and Anti-HBs Antibodies in Chronic Hepatitis B Virus Carriers: Influence of “a” Determinant Variants

Article • Journal of Virology, March 2006, ASM Journals

Thierry Poynard
A prospective assessment of an 'a la carte' regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers

Article • Journal of Viral Hepatitis, March 2006, Wiley

Thierry Poynard
Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: A multicenter phase II study with dose adjustment according to baseline serum bilirubin level

Article • European Journal of Cancer, March 2006, Elsevier

Thierry Poynard
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

Article • BMC Gastroenterology, February 2006, Springer Science + Business Media

Thierry Poynard
Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL)

Article • Gastroentérologie Clinique et Biologique, February 2006, Elsevier

Thierry Poynard
A novel dendritic cell subset involved in tumor immunosurveillance

Article • Nature Medicine, January 2006, Springer Science + Business Media

Thierry Poynard
Intermethod calibration of alanine aminotransferase (ALT) and γ-glutamyltransferase (GGT) results: application to Fibrotest® and Actitest® scores

Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2006, De Gruyter

Thierry Poynard
Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious

Article • Hepatology, January 2006, Wiley

Thierry Poynard
Blood oxidative stress markers are unreliable markers of hepatic steatosis

Article • Alimentary Pharmacology & Therapeutics, January 2006, Wiley

Thierry Poynard
Diagnostic value of FibroTest with normal serum aminotransferases

Article • Hepatology, January 2006, Wiley

Thierry Poynard
Natural history and predictors of disease severity in chronic hepatitis C

Article • Journal of Hepatology, January 2006, Elsevier

Thierry Poynard
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1

Article • Journal of Hepatology, January 2006, Elsevier

Thierry Poynard
Article • Comparative Hepatology, January 2006, Springer Science + Business Media

Thierry Poynard
Lamivudine and HBV-associated nephropathy

Article • Nephrology Dialysis Transplantation, November 2005, Oxford University Press (OUP)

Thierry Poynard
A Dose-Ranging Study of the Efficacy and Tolerability of Entecavir in Lamivudine-Refractory Chronic Hepatitis B Patients

Article • Gastroenterology, October 2005, Elsevier

Thierry Poynard
FAS promoter polymorphisms correlate with activity grade in hepatitis C patients

Article • European Journal of Gastroenterology & Hepatology, October 2005, Wolters Kluwer Health

Thierry Poynard
Longitudinal Assessment of Histology Surrogate Markers (FibroTest-ActiTest) During Lamivudine Therapy in Patients with Chronic Hepatitis B Infection

Article • The American Journal of Gastroenterology, September 2005, Wolters Kluwer Health

Thierry Poynard
A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis B

Article • Gastroenterology, August 2005, Elsevier

Thierry Poynard
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

Article • Gastroenterology, June 2005, Elsevier

Thierry Poynard
Biomarkers as a first-line estimate of injury in chronic liver diseases: Time for a moratorium on liver biopsy?

Article • Gastroenterology, April 2005, Elsevier

Thierry Poynard
Caution before embracing serum markers of liver fibrosis in clinical practice

Article • Gastroenterology, April 2005, Elsevier

Thierry Poynard
Management of chronic hepatitis C in French departments of internal medicine and infectious diseases

Article • Epidemiology and Infection, April 2005, Cambridge University Press

Thierry Poynard
Age and gender will survive to competing risks as fibrosis factors

Article • Gastroenterology, February 2005, Elsevier

Thierry Poynard
Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease

Article • Clinical Gastroenterology and Hepatology, February 2005, Elsevier

Thierry Poynard
Reply:

Article • Hepatology, January 2005, Wiley

Thierry Poynard
A reference material for traceability of aspartate aminotransferase (AST) results

Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2005, De Gruyter

Thierry Poynard
FibroTest-FibroSURE™: towards a universal biomarker of liver fibrosis?

Article • Expert Review of Molecular Diagnostics, January 2005, Taylor & Francis

Thierry Poynard
NASH: a hidden and silent fibroser finally revealed?

Article • Journal of Hepatology, January 2005, Elsevier

Thierry Poynard
Progression of liver fibrosis in women infected with hepatitis C: Long-term benefit of estrogen exposure

Article • Hepatology, January 2005, Wiley

Thierry Poynard
Article • Comparative Hepatology, January 2005, Springer Science + Business Media

Thierry Poynard
Long-term outcome improvement in patients with chronic hepatitis D treated with interferon α

Article • Nature Clinical Practice Gastroenterology &#38 Hepatology, December 2004, Springer Science + Business Media

Thierry Poynard
Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B

Article • European Journal of Gastroenterology & Hepatology, December 2004, Wolters Kluwer Health

Thierry Poynard
Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection

Article • Arthritis & Rheumatism, November 2004, Wiley

Thierry Poynard
The rising health and economic burden of chronic hepatitis C

Article • Journal of Hepatology, August 2004, Elsevier

Thierry Poynard
Prospective Analysis of Discordant Results between Biochemical Markers and Biopsy in Patients with Chronic Hepatitis C

Article • Clinical Chemistry, June 2004, AACC

Thierry Poynard
Treatment of Hepatitis C Virus: The First Decade

Article • Seminars in Liver Disease, May 2004, Thieme Publishing Group

Thierry Poynard
The elusiveness of “normal” ALT in fatty liver

Article • Hepatology, March 2004, Wiley

Thierry Poynard
Comparing the public health burden of chronic hepatitis C and HIV infection in France

Article • Journal of Hepatology, February 2004, Elsevier

Thierry Poynard
The renal tolerance of low-dose adefovir dipivoxil by lamivudine-resistant individuals co-infected with hepatitis B and HIV

Article • Nephrology Dialysis Transplantation, February 2004, Oxford University Press (OUP)

Thierry Poynard
Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors

Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2004, De Gruyter

Thierry Poynard
Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors

Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2004, De Gruyter

Thierry Poynard
Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patients

Article • AIDS, January 2004, Wolters Kluwer Health

Thierry Poynard
Fat, diabetes, and liver injury in chronic hepatitis C

Article • Current Gastroenterology Reports, January 2004, Springer Science + Business Media

Thierry Poynard
Article • Comparative Hepatology, January 2004, Springer Science + Business Media

Thierry Poynard
Article • Comparative Hepatology, January 2004, Springer Science + Business Media

Thierry Poynard
Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy

Article • AIDS, January 2004, Wolters Kluwer Health

Thierry Poynard
Progression of liver fibrosis in women infected with hepatitis C: Long-term benefit of estrogen exposure

Article • Hepatology, January 2004, Wiley

Thierry Poynard
The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C

Article • Hepatology, January 2004, Wiley

Thierry Poynard
The burden cost of French patients suffering from irritable bowel syndrome

Article • Scandinavian Journal of Gastroenterology, January 2004, Taylor & Francis

Thierry Poynard
Treatment of cirrhotic patients in the pegylated interferon era

Article • Digestive and Liver Disease, January 2004, Elsevier

Thierry Poynard
Fibrogenic impact of high serum glucose in chro nic hepatitis C

Article • Journal of Hepatology, December 2003, Elsevier

Thierry Poynard
Viral hepatitis B

Article • The Lancet, December 2003, Elsevier

Thierry Poynard
Viral hepatitis C

Article • The Lancet, December 2003, Elsevier

Thierry Poynard
Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules

Article • Cancer, November 2003, Wiley

Thierry Poynard
Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C

Article • Gut, October 2003, BMJ

Thierry Poynard
Worsening of steatosis and fibrosis progression

Article • Gut, September 2003, BMJ

Thierry Poynard
Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin

Article • Hepatology, August 2003, Wiley

Thierry Poynard
Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B

Article • Journal of Hepatology, August 2003, Elsevier

Thierry Poynard
Reversal of cirrhosis: evidence-based medicine?

Article • Gastroenterology, August 2003, Elsevier

Thierry Poynard
Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C

Article • Hepatology, July 2003, Wiley

Thierry Poynard
Sarcoidosis and interferon therapy: report of five cases and review of the literature

Article • European Journal of Internal Medicine, July 2003, Elsevier

Thierry Poynard
Weight-based ribavirin with pegylated interferon alfa 2b: benefits, risks, and the origin of the evidence

Article • Gastroenterology, June 2003, Elsevier

Thierry Poynard
Noninvasive prediction of fibrosis in patients with chronic hepatitis C

Article • Hepatology, May 2003, Wiley

Thierry Poynard
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial

Article • Journal of Viral Hepatitis, May 2003, Wiley

Thierry Poynard
Anti-tumor necrosis factor-alpha therapy in severe alcoholic hepatitis: are large randomized trials still possible?

Article • Journal of Hepatology, April 2003, Elsevier

Thierry Poynard
Acupuncture for gastrointestinal disorders

Article • Gut, April 2003, BMJ

Thierry Poynard
Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C

Article • Gut, March 2003, BMJ

Thierry Poynard
A comparison of fibrosis progression in chronic liver diseases

Article • Journal of Hepatology, March 2003, Elsevier

Thierry Poynard
Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

Article • AIDS, March 2003, Wolters Kluwer Health

Thierry Poynard
The impact of prior hepatitis B virus infection on liver histology and the response to interferon therapy in chronic hepatitis C

Article • Journal of Viral Hepatitis, March 2003, Wiley

Thierry Poynard
PEG-interferon versus conventional interferon and liver fibrosis: Do we have evidence of superiority?

Article • Gastroenterology, February 2003, Elsevier

Thierry Poynard
Article • Digestive Diseases and Sciences, January 2003, Springer Science + Business Media

Thierry Poynard
Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection

Article • Journal of Viral Hepatitis, January 2003, Wiley

Thierry Poynard
The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C

Article • Journal of Viral Hepatitis, January 2003, Wiley

Thierry Poynard
Truth Survival

Article • Annals of Internal Medicine, December 2002, American College of Physicians

Thierry Poynard
Truth Survival

Article • Annals of Internal Medicine, December 2002, American College of Physicians

Thierry Poynard
Portal lymphocytic infiltrate in alcoholic liver disease

Article • Human Pathology, December 2002, Elsevier

Thierry Poynard
Les interférons ont-ils une action antifibrosante ?Le point de vue de l'hépatologue

Article • La Revue de Médecine Interne, November 2002, Elsevier

Thierry Poynard
Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection

Article • Gastroenterology, November 2002, Elsevier

Thierry Poynard
Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C

Article • Gastroenterology, October 2002, Elsevier

Thierry Poynard
Corrigendum to “Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C” [J Hepatol 36 (2002) 812–818]

Article • Journal of Hepatology, October 2002, Elsevier

Thierry Poynard
Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study

Article • Hepatology, October 2002, Wiley

Thierry Poynard
Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C

Article • The American Journal of Gastroenterology, September 2002, Wolters Kluwer Health

Thierry Poynard
A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients

Article • Metabolism, August 2002, Elsevier

Thierry Poynard
NNRTI-related or -unrelated hepatotoxicity?

Article • Hepatology, August 2002, Wiley

Thierry Poynard
Fatigue in patients with chronic hepatitis C

Article • Journal of Viral Hepatitis, July 2002, Wiley

Thierry Poynard
Truth Survival in Clinical Research: An Evidence-Based Requiem?

Article • Annals of Internal Medicine, June 2002, American College of Physicians

Thierry Poynard
Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C

Article • Journal of Hepatology, June 2002, Elsevier

Thierry Poynard
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

Article • Hepatology, June 2002, Wiley

Thierry Poynard
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C

Article • Gastroenterology, May 2002, Elsevier

Thierry Poynard
Individual and evidence-based

Article • The Lancet, April 2002, Elsevier

Thierry Poynard
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A retrospective multicenter study

Article • Gastroenterology, April 2002, Elsevier

Thierry Poynard
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel

Article • AIDS, April 2002, Wolters Kluwer Health

Thierry Poynard, Dr. Vicente Soriano
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH

Article • Journal of Hepatology, April 2002, Elsevier

Thierry Poynard
Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns

Article • British Journal of Cancer, April 2002, Springer Science + Business Media

Thierry Poynard
Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis

Article • Alimentary Pharmacology & Therapeutics, March 2002, Wiley

Thierry Poynard
Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

Article • Journal of Viral Hepatitis, March 2002, Wiley

Thierry Poynard
Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin

Article • Hepatology, March 2002, Wiley

Thierry Poynard
Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis

Article • Journal of Hepatology, March 2002, Elsevier

Thierry Poynard
Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model

Article • Journal of Viral Hepatitis, March 2002, Wiley

Thierry Poynard
Effect of terlipressin (Glypressin®) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study*

Article • European Journal of Gastroenterology & Hepatology, February 2002, Wolters Kluwer Health

Thierry Poynard
Article • Comparative Hepatology, January 2002, Springer Science + Business Media

Thierry Poynard
Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study

Article • Gut, January 2002, BMJ

Thierry Poynard
Successful control of subfulminant hepatitis related to lamivudine-resistant hepatitis B virus in an HIV-infected patient

Article • AIDS, December 2001, Wolters Kluwer Health

Thierry Poynard
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

Article • The Lancet, September 2001, Elsevier

Thierry Poynard
Factors affecting liver fibrosis in human immunodeficiency virus–and hepatitis C virus–coinfected patients: Impact of protease inhibitor therapy

Article • Hepatology, August 2001, Wiley

Thierry Poynard
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C

Article • Journal of Hepatology, May 2001, Elsevier

Thierry Poynard
The role of interleukin-10 in severe acute alcoholic hepatitis

Article • Clinical Biochemistry, May 2001, Elsevier

Thierry Poynard
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

Article • The Lancet, April 2001, Elsevier

Thierry Poynard
Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome

Article • Alimentary Pharmacology & Therapeutics, March 2001, Wiley

Thierry Poynard
Une hépatite à cytomégalovirus n’est jamais chronique, et peut en cacher une autre !

Article • La Revue de Médecine Interne, February 2001, Elsevier

Thierry Poynard
Early Administration of Vapreotide for Variceal Bleeding in Patients with Cirrhosis

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, January 2001, New England Journal of Medicine (NEJM/MMS)

Thierry Poynard
Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update

Article • Journal of Viral Hepatitis, January 2001, Wiley

Thierry Poynard
Chronic hepatitis B treatment with lamivudine in kidney transplant patients

Article • Transplantation Proceedings, December 2000, Elsevier

Thierry Poynard
Impact of Interferon Alfa-2b and Ribavirin on Progression of Liver Fibrosis in Patients With Chronic Hepatitis C

Article • Hepatology, November 2000, Wiley

Thierry Poynard
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report

Article • Gut, November 2000, BMJ

Thierry Poynard
The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C

Article • Gastroenterology, November 2000, Elsevier

Thierry Poynard
Estimating future hepatitis C morbidity, mortality, and costs in the United States

Article • American Journal of Public Health, October 2000, American Public Health Association

Thierry Poynard
Cost-effectiveness of 24 or 48 weeks of interferon α-2b alone or with ribavirin as initial treatment of chronic hepatitis c

Article • The American Journal of Gastroenterology, June 2000, Wolters Kluwer Health

Thierry Poynard
Liver fibrosis in overweight patients

Article • Gastroenterology, June 2000, Elsevier

Thierry Poynard
Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: effect of corticosteroids

Article • Journal of Hepatology, April 2000, Elsevier

Thierry Poynard
Natural history of HCV infection

Article • Best Practice & Research Clinical Gastroenterology, April 2000, Elsevier

Thierry Poynard
Appropriateness of Liver Biopsy

Article • Canadian Journal of Gastroenterology, January 2000, Hindawi Publishing Corporation

Thierry Poynard
Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: A case-control study

Article • Human Pathology, January 2000, Elsevier

Thierry Poynard
Is an ?� la carte? combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?

Article • Hepatology, January 2000, Wiley

Thierry Poynard
Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections

Article • Journal of Viral Hepatitis, January 2000, Wiley

Thierry Poynard
EFFECT OF INTERFERON THERAPY ON THE NATURAL HISTORY OF HEPATITIS C VIRUS-RELATED CIRRHOSIS AND HEPATOCELLULAR CARCINOMA

Article • Clinics in Liver Disease, November 1999, Elsevier

Thierry Poynard
Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients

Article • Hepatology, November 1999, Wiley

Thierry Poynard
Extrahepatic manifestations of chronic hepatitis C

Article • Arthritis & Rheumatism, October 1999, Wiley

Thierry Poynard
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients

Article • Hepatology, October 1999, Wiley

Thierry Poynard
Focal nodular hyperplasia of the liver on ferumoxides-enhanced MR imaging: features on conventional spin-echo, fast spin-echo and gradient-echo pulse sequences

Article • European Radiology, September 1999, Springer Science + Business Media

Thierry Poynard
A short induction regimen of interferon-α is not effective for treatment of relapse in chronic hepatitis C: a randomized trial

Article • Journal of Viral Hepatitis, September 1999, Wiley

Thierry Poynard
Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe

Article • Journal of Viral Hepatitis, September 1999, Wiley

Thierry Poynard
Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis

Article • European Journal of Gastroenterology & Hepatology, July 1999, Wolters Kluwer Health

Thierry Poynard
Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus

Article • Gut, July 1999, BMJ

Thierry Poynard
Severe acute pancreatitis related to the use of nelfinavir in HIV infection: report of a case with positive rechallenge

Article • AIDS, July 1999, Wolters Kluwer Health

Thierry Poynard
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis

Article • Hepatology, June 1999, Wiley

Thierry Poynard
Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival

Article • Journal of Hepatology, June 1999, Elsevier

Thierry Poynard
Low hepatic iron concentration: evaluation of two complementary methods, colorimetric assay and iron histological scoring

Article • Journal of Clinical Pathology, June 1999, BMJ

Thierry Poynard
Summary of the first international symposium on viral hepatitis

Article • Antiviral Research, June 1999, Elsevier

Thierry Poynard
Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view

Article • Gastroenterology, February 1999, Elsevier

Thierry Poynard
Impact of hepatitis B and C virus on kidney transplantation outcome

Article • Hepatology, January 1999, Wiley

Thierry Poynard
Diurnal variation of serum alanine transaminase activity in chronic liver disease

Article • Hepatology, December 1998, Wiley

Thierry Poynard
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Article • European Journal of Gastroenterology & Hepatology, December 1998, Wolters Kluwer Health

Thierry Poynard
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Article • The Lancet, October 1998, Elsevier

Thierry Poynard
Prolonged treatment with interferon in patients with histologically mild chronic hepatitis C: a decision analysis

Article • Journal of Viral Hepatitis, September 1998, Wiley

Thierry Poynard
No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia

Article • Clinical & Experimental Immunology, July 1998, Wiley

Thierry Poynard
Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease

Article • The Lancet, June 1998, Elsevier

Thierry Poynard
Factors associated with serum alanine transaminase activity in healthy subjects: Consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C

Article • Hepatology, May 1998, Wiley

Thierry Poynard
Hepatitis C: Somber views of natural history and optimistic views of interferon treatment?

Article • Hepatology, May 1998, Wiley

Thierry Poynard
Management of hepatitis C

Article • Journal of Viral Hepatitis, March 1998, Wiley

Thierry Poynard
Randomized, multicentre comparison of sodium alginate and cisapride in the symptomatic treatment of uncomplicated gastro- oesophageal reflux

Article • Alimentary Pharmacology & Therapeutics, February 1998, Wiley

Thierry Poynard
Review article: overview of medical treatments in unresectable hepatocellular carcinoma-an impossible meta-analysis?

Article • Alimentary Pharmacology & Therapeutics, February 1998, Wiley

Thierry Poynard
Antibiotic Prophylaxis for the Prevention of Bacterial Infections in Cirrhotic Patients with Ascites: A Meta-Analysis

Article • Digestion, January 1998, Karger Publishers

Thierry Poynard
Thierry Poynard

Article • The Lancet, August 1997, Elsevier

Thierry Poynard
Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patients

Article • Hepatology, August 1997, Wiley

Thierry Poynard
Effects of cirrhosis, interferon and azathioprine on adverse events in patients with chronic hepatitis C treated with ribavirin

Article • Journal of Viral Hepatitis, July 1997, Wiley

Thierry Poynard
In situ detection of lipid peroxidation by-products in chronic liver diseases

Article • Hepatology, July 1997, Wiley

Thierry Poynard
Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitisC virus

Article • Journal of Viral Hepatitis, May 1997, Wiley

Thierry Poynard
In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features.

Article • Journal of Clinical Pathology, May 1997, BMJ

Thierry Poynard
Review article: critical review of meta-analyses of randomized clinical trials in hepatogastroenterology

Article • Alimentary Pharmacology & Therapeutics, April 1997, Wiley

Thierry Poynard
Natural history of liver fibrosis progression in patients with chronic hepatitis C

Article • The Lancet, March 1997, Elsevier

Thierry Poynard
Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis

Article • Journal of Hepatology, February 1997, Elsevier

Thierry Poynard
Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis

Article • Hepatology, January 1997, Wiley

Thierry Poynard
Histological features predictive of liver fibrosis in chronic hepatitis C infection.

Article • Journal of Clinical Pathology, December 1996, BMJ

Thierry Poynard
Marked increase in serum CA 19-9 level in patients with alcoholic cirrhosis: report of four cases

Article • European Journal of Gastroenterology & Hepatology, November 1996, Wolters Kluwer Health

Thierry Poynard
Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

Article • Hepatology, October 1996, Wiley

Thierry Poynard
An algorithm for the grading of activity in chronic hepatitis C

Article • Hepatology, August 1996, Wiley

Thierry Poynard
Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial

Article • Journal of Hepatology, August 1996, Elsevier

Thierry Poynard
Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone

Article • Gastroenterology, June 1996, Elsevier

Thierry Poynard
Binding of apolipoprotein A-I and acetaldehyde-modified apolipoprotein A-I to liver extracellular matrix

Article • Hepatology, May 1996, Wiley

Thierry Poynard
Binding of apolipoprotein A-I and acetaldehyde-modified apolipoprotein A-I to liver extracellular matrix

Article • Hepatology, May 1996, Wiley

Thierry Poynard
Quantification of apolipoprotein A-I and B messenger RNA in heavy drinkers according to liver disease

Article • Hepatology, January 1996, Wiley

Thierry Poynard
Heptitis B and C virus infection in HBsAg-negative alcoholics without i.v. drug abuse or previous blood transfusions

Article • International Hepatology Communications, August 1995, Elsevier

Thierry Poynard
A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B Hepatitis

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, June 1995, New England Journal of Medicine (NEJM/MMS)

Thierry Poynard
Transforming growth factor?beta 1 (TGF-?1) and TGF-?1 receptors in normal, cirrhotic, and neoplastic human livers*1

Article • Hepatology, March 1995, Elsevier

Thierry Poynard
Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients

Article • The Lancet, February 1995, Elsevier

Thierry Poynard
Prevalence of Cholelithiasis According to Alcoholic Liver Disease: A Possible Role of Apolipoproteins AI and AII

Article • Alcoholism Clinical and Experimental Research, February 1995, Wiley

Thierry Poynard
Weak immunogenicity of the preS2 sequence and lack of circumventing effect on the unresponsiveness to the hepatitis B virus vaccine

Article • Vaccine, January 1995, Elsevier

Thierry Poynard
Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy

Article • Journal of Internal Medicine, December 1994, Wiley

Thierry Poynard
Prednisone-interferon combination in the treatment of chronic hepatitis B: Direct and indirect metanalysis

Article • Hepatology, December 1994, Wiley

Thierry Poynard
Alpha-2-macroglobulin and hepatic fibrosis

Article • Digestive Diseases and Sciences, November 1994, Springer Science + Business Media

Thierry Poynard
Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls

Article • The Lancet, August 1994, Elsevier

Thierry Poynard
Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: Localization and association with progression of liver fibrosis

Article • Hepatology, February 1994, Elsevier

Thierry Poynard
Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: Localization and association with progression of liver fibrosis

Article • Hepatology, February 1994, Wiley

Thierry Poynard
A Two-centre, Randomized, Double-blind Trial of Ornithine Oxoglutarate in 194 Elderly, Ambulatory, Convalescent Subjects

Article • Age and Ageing, January 1994, Oxford University Press (OUP)

Thierry Poynard
No effect of neutralizing antibody to TGF-β1 in acute CC14-induced liver fibrogenesis

Article • Journal of Hepatology, January 1994, Elsevier

Thierry Poynard
Diaphragm Function Is Not Impaired by Pneumoperitoneum After Laparoscopy

Article • Archives of Surgery, April 1993, American Medical Association (AMA)

Thierry Poynard
Laparoscopic treatment without cholecystectomy for gallbladder perforation after liver biopsy

Article • Journal of Hepatology, January 1993, Elsevier

Thierry Poynard
Transforming growth factor beta 1: in situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon.

Article • Gut, January 1993, BMJ

Thierry Poynard
Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial

Article • Hepatology, October 1992, Wiley

Thierry Poynard
Prednisolone in Severe Alcoholic Hepatitis

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 1992, New England Journal of Medicine (NEJM/MMS)

Thierry Poynard
Cirrhosis as an independent risk factor for colonic adenomas.

Article • Gut, April 1992, BMJ

Thierry Poynard
A Randomized Trial of Prednisolone in Patients with Severe Alcoholic Hepatitis

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, February 1992, New England Journal of Medicine (NEJM/MMS)

Thierry Poynard
Anti—pre-S responses and viral clearance in chronic hepatitis B virus infection

Article • Hepatology, January 1992, Wiley

Thierry Poynard
Autoimmune Chronic Hepatitis Exacerbated by Alpha-Interferon

Article • Annals of Internal Medicine, January 1992, American College of Physicians

Thierry Poynard
Computer-Aided Decision Support in Hepatology

Article • Scandinavian Journal of Gastroenterology, January 1992, Taylor & Francis

Thierry Poynard
Portal hypertensive colopathy

Article • Digestive Diseases and Sciences, December 1991, Springer Science + Business Media

Thierry Poynard
Reply

Article • Gastroenterology, December 1991, Elsevier

Thierry Poynard
Prevention of Gastrointestinal Bleeding in Cirrhosis

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 1991, New England Journal of Medicine (NEJM/MMS)

Thierry Poynard
Trauma in Cirrhosis: An Indicator of the Pattern of Alcohol Abuse in Different Societies

Article • Alcoholism Clinical and Experimental Research, June 1991, Wiley

Thierry Poynard
Beta-Adrenergic–Antagonist Drugs in the Prevention of Gastrointestinal Bleeding in Patients with Cirrhosis and Esophageal Varices

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 1991, New England Journal of Medicine (NEJM/MMS)

Thierry Poynard
Devenir des patients après guérison d’une œsophagite Etude prospective de 1 030 patients pendant 6 mois

Article • Acta Endoscopica, May 1991, Lavoisier

Thierry Poynard
Independent risk factors for hepatocellular carcinoma in french drinkers

Article • Hepatology, May 1991, Wiley

Thierry Poynard
A biphasic pattern of anti-pre-s responses in acute hepatitis B virus infection

Article • Hepatology, December 1990, Wiley

Thierry Poynard
Serum Apolipoprotein A-I in Alcoholic Patients with Chronic Calcifying Pancreatitis

Article • Pancreas, September 1990, Wolters Kluwer Health

Dr Philippe H Jais, Thierry Poynard
β-blockers and variceal haemorrhage

Article • The Lancet, August 1990, Elsevier

Thierry Poynard
Long-term results of treatment of vascular malformations of the gastrointestinal tract by neodymium YAG laser photocoagulation

Article • Digestive Diseases and Sciences, July 1990, Springer Science + Business Media

Thierry Poynard
Ursodeoxycholic acid for the treatment of primary biliary cirrhosis

Article • Journal of Hepatology, July 1990, Elsevier

Thierry Poynard
Apolipoproteinemia A and α-fetoprotein in the diagnosis of hepatocellular carcinoma and cirrhosis: Several interpretations

Article • Hepatology, May 1990, Wiley

Thierry Poynard
Diagnostic Value of Serum gamma-Glutamyl-Transferase Activity and Mean Corpuscular Volume in Alcoholic Patients with or without Cirrhosis

Article • Alcoholism Clinical and Experimental Research, April 1990, Wiley

Thierry Poynard
Endoscopic Nd-YAG laser therapy as palliative treatment for esophageal and cardial cancer

Article • Digestive Diseases and Sciences, March 1990, Springer Science + Business Media

Thierry Poynard
Expression of histocompatibility antigens and characterization of the lymphocyte infiltrate in hyperplastic polyps of the large bowel

Article • Human Pathology, March 1990, Elsevier

Thierry Poynard
Statistics in clinical trials

Article • The Lancet, March 1990, Elsevier

Thierry Poynard
Randomized Double-Blind Clinical Trial of Aluminum Phosphate versus Ranitidine in the Acute Treatment of Duodenal Ulcer

Article • Digestion, January 1990, Karger Publishers

Thierry Poynard
Serial passage of West-European sporadic non-A non-B hepatitis in rhesus monkeys by inoculation with fecal extracts

Article • Journal of Medical Virology, January 1990, Wiley

Thierry Poynard
Apolipoprotein A1 is a Serum and Tissue Marker of Liver Fibrosis in Alcoholic Patients

Article • Alcoholism Clinical and Experimental Research, December 1989, Wiley

Thierry Poynard
Endoscopic Nd-YAG laser therapy for palliative treatment of colorectal adenocarcinoma: A multivariate prognostic analysis

Article • Lasers in Medical Science, December 1989, Springer Science + Business Media

Thierry Poynard
Endoscopic laser therapy for duodenal villous adenoma

Article • Digestive Diseases and Sciences, September 1989, Springer Science + Business Media

Thierry Poynard
A randomized study of a coaxial fiber versus a naked fiber for endoscopic Nd:YAG laser therapy of esophageal and rectal tumors

Article • Gastrointestinal Endoscopy, May 1989, Elsevier

Thierry Poynard
Successful ablation of a large fibrovascular polyp of the esophagus by endoscopic Nd:YAG laser therapy

Article • Gastrointestinal Endoscopy, May 1989, Elsevier

Thierry Poynard
RECTAL AND COLONIC VARICES IN CIRRHOSIS

Article • The Lancet, March 1989, Elsevier

Thierry Poynard
A Randomised Controlled Study of Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis

Article • Drugs, January 1989, Springer Science + Business Media

Thierry Poynard
Prognostic evaluation in cirrhosis

Article • Hepatology, July 1988, Wiley

Thierry Poynard
Detection of hepatitis B surface antigen by a monoclonal radioimmunoassay in the serum of alcoholic patients

Article • Journal of Gastroenterology and Hepatology, April 1988, Wiley

Thierry Poynard
Response to hewitt et al: Retrieval of randomized clinical trials in liver disease

Article • Controlled Clinical Trials, March 1988, Elsevier

Thierry Poynard
A DECADE OF CAMPYLOBACTER PYLORI

Article • The Lancet, February 1988, Elsevier

Thierry Poynard
Observer Variation in Assessment of Liver Biopsies of Alcoholic Patients

Article • Alcoholism Clinical and Experimental Research, February 1988, Wiley

Thierry Poynard
Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis

Article • Journal of Hepatology, January 1988, Elsevier

Thierry Poynard
Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A prospective study of factors associated with rebleeding

Article • Hepatology, May 1987, Wiley

Thierry Poynard
Relationship between degree of portal hypertension and liver histologic lesions in patients with alcoholic cirrhosis

Article • Digestive Diseases and Sciences, April 1987, Springer Science + Business Media

Thierry Poynard
Failure of haemodynamic measurements to predict recurrent gastrointestinal bleeding in cirrhotic patients receiving propranolol

Article • Journal of Hepatology, January 1987, Elsevier

Thierry Poynard
Gastric phytobezoar destruction by Nd:YAG laser therapy

Article • Gastrointestinal Endoscopy, December 1986, Elsevier

Thierry Poynard
Apolipoprotein AI and alcoholic liver disease

Article • Hepatology, November 1986, Wiley

Thierry Poynard
Multivariate analysis of prognostic factors in fulminant hepatitis B

Article • Hepatology, July 1986, Wiley

Thierry Poynard
Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives

Article • Gastroenterology, April 1986, Elsevier

Thierry Poynard
A randomized clinical trial of supplementary parenteral nutrition in jaundiced alcoholic cirrhotic patients

Article • Hepatology, March 1986, Wiley

Thierry Poynard
The retrieval of randomized clinical trials in liver disease from the medical literature

Article • Controlled Clinical Trials, December 1985, Elsevier

Thierry Poynard
Prognostic value of serum fibronectin concentration in alcoholic cirrhotic patients

Article • Hepatology, September 1985, Wiley

Thierry Poynard
Psoriasis, alcohol, and liver disease.

Article • BMJ, July 1985, BMJ

Thierry Poynard
Relationships between liver histologic lesions and portal hypertension in patients with alcoholic cirrhosis

Article • Hepatology, July 1985, Wiley

Thierry Poynard
Propranolol for prevention of recurrent GI bleeding

Article • Hepatology, May 1985, Wiley

Thierry Poynard
Adrenocorticosteroid administration and peptic ulcer: A critical analysis

Article • Journal of Chronic Diseases, January 1985, Elsevier

Thierry Poynard
A Randomized Controlled Study of Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis: A Final Report

Article • Hepatology, May 1984, Wiley

Thierry Poynard
HEPATITIS B VACCINE: A DIAGNOSTIC TEST FOR PREVIOUS HEPATITIS B VIRUS INFECTION?

Article • The Lancet, April 1984, Elsevier

Thierry Poynard
Prognostic Value of Total Serum Bilirubin/γ-Glutamyl Transpeptidase Ratio in Cirrhotic Patients

Article • Hepatology, March 1984, Wiley

Thierry Poynard
Adrenocorticosteroid Therapy and Peptic-Ulcer Disease

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, January 1984, New England Journal of Medicine (NEJM/MMS)

Thierry Poynard
Efficiency of respiratory assistance in cirrhotic patients with liver failure

Article • Intensive Care Medicine, September 1983, Springer Science + Business Media

Thierry Poynard
Recurrent bleeding and propranolol?

Article • Digestive Diseases and Sciences, July 1983, Springer Science + Business Media

Thierry Poynard
Relations Between Effectiveness of a Diagnostic Test, Prevalence of the Disease, and Percentages of Uninterpretable Results

Article • Medical Decision Making, August 1982, SAGE Publications

Thierry Poynard
Secretory Diarrhea and Prostaglandin D2Overproduction in Systemic Mastocytosis

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 1982, New England Journal of Medicine (NEJM/MMS)

Thierry Poynard
Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: Assessment by the artificial pancreas

Article • Diabetologia, July 1982, Springer Science + Business Media

Thierry Poynard
Propranolol in Gastrointestinal Bleeding from Cirrhosis

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, June 1982, New England Journal of Medicine (NEJM/MMS)

Thierry Poynard
Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis

Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 1981, New England Journal of Medicine (NEJM/MMS)

Thierry Poynard
Upper digestive tract hemorrhage in cirrhotic patients

Article • Digestive Diseases and Sciences, March 1981, Springer Science + Business Media

Thierry Poynard
PECTIN EFFICACY IN INSULIN-TREATED DIABETICS ASSESSED BY THE ARTIFICIAL PANCREAS

Article • The Lancet, January 1980, Elsevier

Thierry Poynard
Hepatocellular Carcinoma in NAFLD

Article • Wiley

Thierry Poynard
Alcoholic Liver Disease

Article • Wiley

Thierry Poynard
Progression of Fibrosis

Article • Wiley

Thierry Poynard

Search Kudos

Main menu

Discover

Subjects on Kudos

Services and resources

Admin

All Stories